BHST Share Price Performance
US$5.23
-1.06 (-16.85%)
61.7% undervalued intrinsic discount
US$13.67
Fair Value
Price US$5.23
AnalystConsensusTarget US$13.67
Fair ValueUS$13.67
Share Pricen/a
BioHarvest Sciences Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
BHST Community Narratives
AN
Fair Value US$13.67 61.7% undervalued intrinsic discount
Plant Based CDMO Expansion And Health Pros Network Will Drive Long Term Upside
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Plant Based CDMO Expansion And Health Pros Network Will Drive Long Term Upside
Catalysts About BioHarvest Sciences BioHarvest Sciences develops and commercializes high value plant derived compounds using its proprietary Botanical Synthesis platform, serving nutraceutical, pharmaceutical, cosmetic and nutrition end markets. What are the underlying business or industry changes driving this perspective?Read more
1
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$13.67
61.7% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
42.54% p.a.
Profit Margin
14.28%
Future PE
34.6x
Price in 2028
US$9.41
Trending Discussion
Recently Updated Narratives
AN
Plant Based CDMO Expansion And Health Pros Network Will Drive Long Term Upside
Fair Value: US$13.67 61.7% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
BioHarvest Sciences Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -0.52
- 59.21%
- -36.33%
- 78.1%
About BHST
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.
